Kalinia, Shervin – Trademark Portfolio

Entity Type: 01

Kalinia, Shervin has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include CALMING BLENDS. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 5 (Pharmaceuticals). This trademark owner is based in Houston, TX.

11927 Wink Rd.

Houston, TX 77024

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Kalinia, Shervin's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Kalinia, Shervin have?

Kalinia, Shervin has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Kalinia, Shervin file in?

Kalinia, Shervin files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.

What are Kalinia, Shervin's most well-known trademarks?

Kalinia, Shervin's registered trademark portfolio includes well-known marks such as CALMING BLENDS. These are among 1 currently registered trademark in the portfolio.

What is Kalinia, Shervin's trademark registration success rate?

Kalinia, Shervin has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.